Carasent ASA – Private placement of new shares successfully placed


Carasent ASA - Private placement of new shares successfully placed
Oslo, Norway, Tuesday 25 May 2021

Reference is made to the stock exchange announcement by Carasent ASA (OSE: CARA)
("Carasent" or the "Company") on Tuesday 25 May 2021 regarding the contemplated,
fully underwritten, private placement of 11,007,031 new shares (the "Offer
Shares") (representing ~20% of the outstanding share capital of the Company)
(the "Private Placement").

The Company is pleased to announce that it has allocated 11,007,031 new shares
in the Private Placement at a subscription price of NOK 33.40 per share, raising
gross proceeds of NOK 368 million. DNB Markets, a part of DNB Bank ASA acted as
Sole Manager (the "Manager") in connection with the Private Placement.

The Company intends to use the net proceeds from the Private Placement to
finance the acquisition of Metodika AB, as announced on 25 May 2021, finance
future potential acquisitions and strengthen the ability to capitalize on
organic growth opportunities, as well as for general corporate purposes.

The share capital increase pertaining to the Private Placement was resolved by
the Board of Directors of the Company (the "Board") on 25 May 2021 pursuant to
an authorization granted by the Company's general meeting held 14 January 2021
(the "Authorization"). Notification of allotment of the Offer Shares including
settlement instructions will be sent to the applicants through a notification
from the Manager on 26 May 2021.

Offer Shares will be settled with existing and unencumbered shares in the
Company that are already listed on the Oslo Stock Exchange, pursuant to a share
lending agreement between the Company, Aeternum Capital AS, Windchange AS,
Factis Invest AB and DNB Markets in order to facilitate delivery of listed
shares to investors on a delivery versus payment basis. Pursuant to these Share
Lending Agreements, Aeternum Capital AS has lent out 8,000,000 shares,
Windchange AS has lent out 2,000,000 shares and Factis Invest AB has lent out

The Offer Shares will thus be tradable from allocation. DNB Markets will settle
the share loan with a corresponding number of new shares in the Company to be
issued by the Board pursuant to the Authorization (the "New Shares"). All New
Shares will be registered on the Company's ordinary ISIN and will be listed upon

Following registration of the share capital increase pertaining to the Private
Placement, the Company will have a share capital of NOK 87,968,197, divided into
66,042,190 shares, each with a nominal value of NOK 1.332.

The Board of Directors has considered the Private Placement in light of the
equal treatment obligations under the Norwegian Securities Trading Act and Oslo
Børs' Circular no. 2/2014, and is of the opinion that the Private Placement is
in compliance with these requirements. The Board is of the view that it is in
the common interest of the Company and its shareholders to raise equity through
a private placement, in view of the current market conditions and the growth
opportunities currently available to the Company. A private placement enables
the Company to raise capital in an efficient manner, and the Private Placement
is structured to ensure that a market based subscription price is achieved.

For additional information, please contact:

Dennis Höjer, CEO
+46 733 28 49 22

Johan Lindqvist, Chairman
+46 733 55 09 35

Important Notices

This document is not an offer to sell or a solicitation of offers to purchase or
subscribe for shares. Copies of this document may not be sent to jurisdictions,
or distributed in or sent from jurisdictions, in which this is barred or
prohibited by law. The information contained herein shall not constitute an
offer to sell or the solicitation of an offer to buy, in any jurisdiction in
which such offer or solicitation would be unlawful prior to registration,
exemption from registration or qualification under the securities laws of any

This communication may not be published, distributed or transmitted in or into
the United States, Canada, Australia, the Hong Kong Special Administrative
Region of the People's Republic of China, South Africa or Japan and it does not
constitute an offer or invitation to subscribe for or purchase any securities in
such countries or in any other jurisdiction. In particular, the document and the
information contained herein should not be distributed or otherwise transmitted
into the United States of America or to U.S. persons (as defined in the U.S.
Securities Act of 1933, as amended (the "Securities Act")) or to publications
with a general circulation in the United States of America. This document is not
an offer for sale of securities in the United States. The securities referred to
herein have not been and will not be registered under the Securities Act, or the
laws of any state, and may not be offered or sold in the United States of
America absent registration under or an exemption from registration under
Securities Act. Carasent does not intend to register any part of the offering in
the United States. There will be no public offering of the securities in the
United States of America.
The information contained herein does not constitute an offer of securities to
the public in the United Kingdom. No prospectus offering securities to the
public will be published in the United Kingdom. This document is only being
distributed to and is only directed at (i) persons who are outside the United
Kingdom or (ii) to investment professionals falling within article 19(5) of the
Financial Services and Markets Act 2000 (Financial Promotion) Order 2005 (the
"Order") or (iii) high net worth entities, and other persons to whom it may
lawfully be communicated, falling within article 49(2)(a) to (d) of the Order
(all such persons together being referred to as "relevant persons"). The
securities are only available to, and any invitation, offer or agreement to
subscribe, purchase or otherwise acquire such securities will be engaged in only
with, relevant persons. Any person who is not a relevant person should not act
or rely on this document or any of its contents.

This announcement is an advertisement and does not constitute a prospectus for
the purposes of the Prospectus Regulation (EU) 2017/1129 (as amended, together
with any applicable implementing measures in any Member State, the "Prospectus
Regulation"). In any EEA Member State that has implemented the Prospectus
Regulation, this communication is only addressed to and is only directed at
qualified investors in that Member State within the meaning of the Prospectus
Investing in securities involves certain risks.

This publication may contain specific forward-looking statements, e.g.
statements including terms like "believe", "assume", "expect", "forecast",
"project", "may", "could", "might", "will" or similar expressions. Such forward
-looking statements are subject to known and unknown risks, uncertainties and
other factors which may result in a substantial divergence between the actual
results, financial situation, development or performance of Carasent and those
explicitly or implicitly presumed in these statements. Against the background of
these uncertainties, readers should not rely on forward-looking statements.
Carasent assumes no responsibility to update forward-looking statements or to
adapt them to future events or developments.

This announcement is made by and, and is the responsibility of, the Company. The
Manager is acting exclusively for the Company and no one else and will not be
responsible to anyone other than the Company for providing the protections
afforded to their respective clients, or for advice in relation to the contents
of this announcement or any of the matters referred to herein.

Neither the Manager nor any of its affiliates makes any representation as to the
accuracy or completeness of this announcement and does not accept any
responsibility for the contents of this announcement or any matters referred to

This information is subject to the disclosure requirements pursuant to section 5
-12 and 4-2 of the Norwegian Securities Trading Act.

More Press releases